Please upgrade your Flash Player Tagged in: Access to health care, Administrative fees, Administrative procedure, Administrative remedies, Animals, Antibiotics, Authorization, Budgets, Business, Cancer, Child health, Children, Civil liberties, Clinical trials, Communications, Computer security measures, Conflict of interests, Congressional investigations, Congressional reporting requirements, Consumer education, Consumers, Cosmetics, Data banks, Deceptive advertising, Department of Health and Human Services, Directories, Drug advertising, Drug approvals, Drug industry, Drug interactions, Drugs, Electronic data interchange, Electronic government information, Executive departments, Executive reorganization, Federal advisory bodies, Federal aid to research, Food, Food and Drug Administration (FDA), Food safety, Foreign corporations, Foundations, Fund raising, Gifts, Government information, Government paperwork, Government publicity, Health information systems, Health policy, Identification devices, Imaging systems in medicine, Imports, Intellectual property, Inventions, Inventors, Labeling, Law, Licenses, Medical care, Medical ethics, Medical innovations, Medical instruments and apparatus, Medical records, Medical research, Medical supplies, Medicine, National Institutes of Health (NIH), Nonprofit organizations, Nosocomial infections, Nuclear medicine, Orphan drugs, Patents, Pediatrics, Performance measurement, Pharmaceutical research, Physicians, Product counterfeiting, Product development, Product safety, Profit, Public-private partnerships, Research and development, Research grants, Right of privacy, Risk, Science policy, Small business, Social services, Technology, Telecommunication, Telephone, Television advertising, Trade, User charges, Veterinary medicine
Latest Update: Wednesday, July, 09th 2008
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. 7/11/2007--Passed House amended. (There is 1 other summary) Food and Drug Administration Amendments Act of 2007 - Title I: Prescription Drug User Fee Amendments of 2007 - (Sec. 101) Prescription Drug User Fee Amendments of 2007 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to include postmarket safety activities within the process for the review of human drug applications or supplements, including: (1) developing and using improved adverse event data collection systems and improved analytical tools to assess potential safety problems; (2) implementing and enforcing provisions relating to postapproval studies, clinical trials, labeling changes, and risk [...] show full description
- 07/16/2007 - Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 270.
- 07/11/2007 - Reported by the Committee on Energy and Commerce. H. Rept. 110-225.
- 07/11/2007 - Placed on the Union Calendar, Calendar No. 140.
- 07/11/2007 - Mr. Dingell moved to suspend the rules and pass the bill, as amended.
- 07/11/2007 - Considered under suspension of the rules. (consideration: CR H7568-7606)
show all actions- 07/16/2007 - Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 270.
- 07/11/2007 - Reported by the Committee on Energy and Commerce. H. Rept. 110-225.
- 07/11/2007 - Placed on the Union Calendar, Calendar No. 140.
- 07/11/2007 - Mr. Dingell moved to suspend the rules and pass the bill, as amended.
- 07/11/2007 - Considered under suspension of the rules. (consideration: CR H7568-7606)
- 07/11/2007 - At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
- 07/11/2007 - Considered as unfinished business. (consideration: CR H7629)
- 07/11/2007 - On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 403 - 16 (Roll no. 617). (text: CR H7568-7600)
- 07/11/2007 - Motion to reconsider laid on the table Agreed to without objection.
- 07/11/2007 - DEBATE - The House proceeded with forty minutes of debate on H.R. 2900.
- 06/28/2007 - Referred to the House Committee on Energy and Commerce.
- 06/28/2007 - Mr. Pallone asked unanimous consent that the Committee on Energy and Commerce have until midnight on July 9 to file a report on H.R. 2900. Agreed to without objection.
show latest actions
|
Important People
Latest News
Searching for articles...
|
Comment on Bill - Be the first to leave a comment!